An intra-oral, nanoemulsion assists in balancing the histamine response in subjects when orally administered. The intra-oral, nanoemulsion includes at least one monolayer surfactant bound particle and a continuous phase. The monolayer surfactant bound particles are carried by the continuous phase. A method of making and of administering the nanoemulsion to balance the histamine response in subjects also is described. The nanoemulsion is ingestible and edible.

An intra-oral, nanoemulsion assists in balancing the histamine response in subjects when orally administered. The intra-oral, nanoemulsion includes at least one monolayer surfactant bound particle and a continuous phase. The monolayer surfactant bound particles are carried by the continuous phase. A method of making and of administering the nanoemulsion to balance the histamine response in subjects also is described. The nanoemulsion is ingestible and edible.

Herbal composition for treatment and management of Thyroid dysfunction and method of preparation are disclosed herein. The disclosed composition including herbs and bhasmas may be used to treat Thyroid dysfunction and associated complications such as Hashimoto's thyroiditis, hyperthyroidism, hypothyroidism, Goiter, Thyrotoxicosis, Graves' disease, autoimmune thyroiditis etc. The method disclosed herein may be used as the main line of treatment or as supportive medication.

Herbal composition for treatment and management of Thyroid dysfunction and method of preparation are disclosed herein. The disclosed composition including herbs and bhasmas may be used to treat Thyroid dysfunction and associated complications such as Hashimoto's thyroiditis, hyperthyroidism, hypothyroidism, Goiter, Thyrotoxicosis, Graves' disease, autoimmune thyroiditis etc. The method disclosed herein may be used as the main line of treatment or as supportive medication.

Herbal composition for treatment and management of Thyroid dysfunction and method of preparation are disclosed herein. The disclosed composition including herbs and bhasmas may be used to treat Thyroid dysfunction and associated complications such as Hashimoto's thyroiditis, hyperthyroidism, hypothyroidism, Goiter, Thyrotoxicosis, Graves' disease, autoimmune thyroiditis etc. The method disclosed herein may be used as the main line of treatment or as supportive medication.

Anti-fungal compositions, methods of making same, uses thereof, and kits including one or more composition(s). A composition may include optionally, copper sulfate; a copper metal component; and one or more organic antifungal component(s). A copper metal component may be a copper powder. An organic antifungal component may be tea tree oil, jojoba oil, or the like, or a combination thereof. A composition may also include one or more carbon source(s) and/or one or more essential oil(s). A composition may be used to treat fungal infections or treat medical equipment, medical devices, food-handling implements, or the like.

Anti-fungal compositions, methods of making same, uses thereof, and kits including one or more composition(s). A composition may include optionally, copper sulfate; a copper metal component; and one or more organic antifungal component(s). A copper metal component may be a copper powder. An organic antifungal component may be tea tree oil, jojoba oil, or the like, or a combination thereof. A composition may also include one or more carbon source(s) and/or one or more essential oil(s). A composition may be used to treat fungal infections or treat medical equipment, medical devices, food-handling implements, or the like.

Preparations and formulations capable of crossing and incorporating into a membrane of a cell or an organelle or an exosome are described. Methods of treatments utilizing the preparations and formulations are also described.

Preparations and formulations capable of crossing and incorporating into a membrane of a cell or an organelle or an exosome are described. Methods of treatments utilizing the preparations and formulations are also described.

Provided is a device suitable for direct topical administration of a pharmaceutical composition comprising at least one active component selected from the group consisting of cannabinoids, terpenes, flavonoids, CB1 receptor agonists, CB2 receptor agonists and combinations thereof to a region of the oral cavity of a subject and methods of use thereof. The device comprises a solid substrate having at least a portion configured and dimensioned to be contacted with the region of the oral cavity of the subject; and an amount of the pharmaceutical composition associated with at least a portion of the solid substrate, wherein the amount of pharmaceutical composition is at least partially releasable from the portion of solid substrate.